Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency
- 20 May 2020
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 40 (8), 1917-1925
- https://doi.org/10.1111/liv.14518
Abstract
Background & Aim The canalicular bile salt export pump (BSEP/ABCB11) of hepatocytes is the main adenosine triphosphate (ATP)‐binding cassette (ABC) transporter responsible for bile acid secretion. Mutations in ABCB11 cause several cholestatic diseases, including progressive familial intrahepatic cholestasis type 2 (PFIC2) often lethal in absence of liver transplantation. We investigated in vitro the effect and potential rescue of a BSEP mutation by ivacaftor, a clinically approved cystic fibrosis transmembrane conductance regulator (CFTR/ABCC7) potentiator. Methods The p.T463I mutation, identified in a PFIC2 patient and located in a highly conserved ABC transporter motif, was studied by 3D structure modeling. The mutation was reproduced in a plasmid encoding a rat Bsep‐green fluorescent protein. After transfection, mutant expression was studied in Can 10 cells. Taurocholate transport activity and ivacaftor effect were studied in Madin‐Darby canine kidney (MDCK) clones co‐expressing the rat sodium‐taurocholate co‐transporting polypeptide (Ntcp/Slc10A1). Results As the wild‐type protein, BsepT463I was normally targeted to the canalicular membrane of Can 10 cells. As predicted by 3D structure modeling, taurocholate transport activity was dramatically low in MDCK clones expressing BsepT463I. Ivacaftor treatment increased by 1.7‐fold taurocholate transport activity of BsepT463I (p), reaching 95% of Bsepwt activity. These data suggest that the p.T463I mutation impairs ATP‐binding, resulting in Bsep dysfunction that can be rescued by ivacaftor. Conclusion These results provide experimental evidence of ivacaftor therapeutic potential for selected patients with PFIC2 caused by ABCB11 missense mutations affecting BSEP function. This could represent a significant step forward for the care of patients with BSEP deficiency.Keywords
This publication has 35 references indexed in Scilit:
- Expression Profile of Drug and Nutrient Absorption Related Genes in Madin-Darby Canine Kidney (MDCK) Cells Grown under Differentiation ConditionsPharmaceutics, 2012
- Degenerate ABC composite site is stably glued together by trapped ATPThe Journal of general physiology, 2010
- ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural historyJournal of Hepatology, 2010
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences of the United States of America, 2009
- Progressive familial intrahepatic cholestasisOrphanet Journal of Rare Diseases, 2009
- Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicingJournal of Hepatology, 2008
- Severe Bile Salt Export Pump Deficiency: 82 Different ABCB11 Mutations in 109 FamiliesGastroenterology, 2008
- Expression, localization, and inducibility by bile acids of hepatobiliary transporters in the new polarized rat hepatic cell lines, Can 3−1 and Can 10Cell and tissue research, 2007
- Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pumpAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin–Darby canine kidney cellsJournal of Gastroenterology and Hepatology, 2004